Portfolio company
Aerion Bioscience
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a blood test using a six-protein panel and algorithm to detect lung cancer in high-risk individuals.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Oxford Cancer Analytics
The company develops liquid biopsy blood tests using proteomics and machine learning for early lung cancer detection for healthcare providers and screening programmes.
Amadix
This company develops blood-based liquid biopsy tests for the early detection of colorectal, lung and pancreatic cancer in patients and healthcare settings.
Orbit Genomics
This company develops AI-powered genomic tests for healthcare providers and patients to diagnose lung cancer and evaluate risks for chronic diseases.
Infiniplex
This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.
OXCan
This company develops blood tests using proteomics and machine learning to enable early cancer detection for healthcare providers and patients.
20/20 BioLabs
This company develops AI-powered blood tests for the early detection and prevention of cancers and chronic diseases for individuals and healthcare providers.
Epiliquid
This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.
Oncoliq
This company develops liquid biopsy tests using molecular biology and machine learning for early cancer detection in clinical and screening settings.